• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1125225-28
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 09/12/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(6).Evaluation summary: the device was returned for analysis.The reported material deformation and the reported difficult to remove were confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that as during stent delivery system (sds) advancement, resistance was met with the moderately calcified lesion resulting in the reported failure to advance.Interaction with the guiding catheter as the device was attempted to be removed resulted in the reported/noted stent damage (flared/crushed) thus resulting in the reported difficult to remove.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event or Problem Description
It was reported that a 2.25x28mm xience alpine stent delivery system (sds) failed to cross the circumflex coronary artery, moderately calcified lesion.Following, a stent strut was noted to have been lifted.While attempting to remove the sds, resistance was met at the guide catheter entry and the sds could not be removed.Therefore, all devices were removed as a single unit.There were no adverse patient effects and there was no clinically significant delay.There was no additional information provided regarding this issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key6915953
Report Number2024168-2017-07980
Device Sequence Number13618555
Product Code NIQ
UDI-Device Identifier08717648199103
UDI-Public08717648199103
Combination Product (Y/N)N
Initial Reporter StateWV
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date (Section B) 10/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/29/2020
Device Catalogue Number1125225-28
Device Lot Number7052341
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/21/2017
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/15/2017
Initial Report FDA Received Date10/05/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age63 YR
Patient Weight126
-
-